dacomitinib (Compound)

Synonyms:Dacomitinib, 1110813-31-4, PF-00299804, PF299804, Dacomitinib (PF299804, PF299), Dacomitinib anhydrous, (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide, (E)-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-Methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enaMide, PF-299804, Dacomitinib (PF299804), 2XJX250C20, PF 00299804-03, Dacomitinib (INN), (2e)-N-{4-[(3-Chloro-4-Fluorophenyl)amino]-7-Methoxyquinazolin-6-Yl}-4-(Piperidin-1-Yl)but-2-Enamide, DACOMITINIB [INN], PF-299804 (Dacomitinib PF-00299804), (E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide, Dacomitinib [USAN:INN], dacomitinibum, UNII-2XJX250C20, PF299, (E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide, PF-299, DACOMITINIB [WHO-DD], MLS006011275, GTPL7422, CHEMBL2110732, CHEBI:91466, DTXSID50149493, EX-A030, CHEBI:132268, BDBM112499, Dacomitinib (PF-00299804), AMY21292, BCP02530, MFCD19443734, NSC765888, NSC800084, s2727, AKOS025401818, CCG-264987, CS-0500, DB11963, NSC-765888, NSC-800084, US8623883, No. 2, NCGC00263185-09, NCGC00263185-10, AC-25915, AS-57686, HY-13272, SMR004703025, D5450, SW219155-1, D09883, Dacomitinib (PF299804, PF-00299804), EN300-7406881, J-500784, Q17130597, (2E)-N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-METHOXYQUINAZOLIN-6-YL)-4-PIPERIDIN-1-YLBUT-2-ENAMIDE, (2E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide, (E)-N-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide, (E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide, 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-, (2E)-

Pubchem:PUBCHEM:11511120

Id:10899be2-f65f-5e4c-b5c6-d158b460a545

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View dacomitinib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for dacomitinib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with dacomitinib.

Results found

Linked to

	Label	Description
	BRD-K57169635-001-04-5 Substance (Entity type)	A Substance
	DCSTRUCT ID 05297 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05297; PubChem_CID:11511120, FILE=drugcentral_drug_05297.json)
	dacomitinib (9373d438-e06b-48bb-96b4-35728b32e365) Collection (Entity type)	Metadatata for dacomitinib
	dacomitinib positively regulates ATF5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	dacomitinib positively regulates SCD Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	dacomitinib bioactivity Receptor tyrosine-protein kinase erbB-4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	dacomitinib positively regulates CFB Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	dacomitinib negatively regulates PHLDA1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	dacomitinib negatively regulates SFRP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	dacomitinib positively regulates HMOX1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS